News & Updates
Showing Paediatrics articles
Showing
Show Multimedia Only

Injectable HIV Tx trumps daily pill in virally suppressed adolescents
04 Sep 2026
byAudrey Abella
The week-96 LATA trial results demonstrate the superiority of long-acting injectable (LAI) cabotegravir/rilpivirine (CAB/RPV) to tenofovir/lamivudine/dolutegravir (TLD) for maintaining virologic suppression in adolescents with HIV in sub-Saharan Africa.








